Meeting report: consensus from the first and second Global Workshops in Melanoma November 19-20, 2008-Reference-Cited by-同舟云学术

Meeting report: consensus from the first and second Global Workshops in Melanoma November 19-20, 2008

Published:2009-10 Issue:5 Volume:22 Page:532-543
ISSN:1755-1471
Container-title:Pigment Cell & Melanoma Research
language:en
Short-container-title:

Author:

Agarwala Sanjiv S.,Becker Jurgen C.,Eggermont Alexander M.,Flaherty Keith T.,Garbe Claus,Goldstein Alisa M.,Halpern Allan,Kashani-Sabet Mohammed,Hauschild Axel,Kirkwood John M.,Leachman Sancy,Lorigan Paul,McMahon Martin,Messina Jane,Ribas Antoni,Samlowski Wolfram E.,Schadendorf Dirk,Sondak Vernon K.

Publisher

Wiley

Subject

Dermatology,General Biochemistry, Genetics and Molecular Biology,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1755-148X.2009.00602.x/fullpdf

Reference8 articles.

1. Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group;Bedikian;J. Clin. Oncol.,2006

2. Post-surgery adjuvant therapy with intermediate doses of interferon alfa 2b versus observation in patients with stage IIb/III melanoma (EORTC 18952): randomised controlled trial;Eggermont;Lancet,2005

3. Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial;Eggermont;Lancet,2008

4. Prognostic significance of autoimmunity during treatment of melanoma with interferon;Gogas;N. Engl. J. Med.,2006

5. Results of a phase III, randomized, placebo-controlled study of sorafenib in combination with carboplatin and paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanoma;Hauschild;J. Clin. Oncol.,2009

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Driver Mutations in Melanoma: Lessons Learned From Bench-to-Bedside Studies;Current Oncology Reports;2012-06-22

2. Evaluation of new iodinated acridine derivatives for targeted radionuclide therapy of melanoma using 125I, an Auger electron emitter;Investigational New Drugs;2010-06-22